View in EDS HTML Full Text PDF Full Text

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial.

Saved in:
Bibliographic Details
Title: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial.
Authors: Martinon-Torres F; Translational Paediatrics and Infectious Diseases Section, Paediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, 15701, Santiago de Compostela, Spain.; Genetics, Vaccines, and Infections Research Group (GENVIP), Healthcare Research Institute of Santiago de Compostela, University of Santiago de Compostela, 15701, Santiago de Compostela, Spain.; CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, 28222, Madrid, Spain., Virta MM; Finnish Vaccine Research, Järvenpää Clinic, Mannilantie, Järvenpää, Finland., Koski S; Finnish Vaccine Research, Helsinki South Clinic, Vuorikatu, Helsinki, Finland.; Finnish Vaccine Research, Helsinki East Clinic, Itäkeskuksen Kauppakeskus, Agenttitalo, Turunlinnantie, Helsinki, Finland., de la Cueva IS; Unidad de Investigación, Grupo IHP (Instituto Hispalense de Pediatría), Seville, Spain., Szymanski HT; Department of Pediatrics, Szpital im. Swietej Jadwigi Slaskiej w Trzebnicy, Prusicka 53-55, 55-100, Trzebnica, Poland., Bosis S; Pneumology and Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Drăgănescu AC; National Institute for Infectious Diseases 'Prof. Dr. Matei Bals', Bucharest, Romania.; Department of Pediatrics, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Silfverdal SA; Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden., Zambrano B; Global Clinical Development Strategy, Sanofi, Montevideo, Uruguay., Dhingra MS; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA., B'Chir S; Global Biostatistical Sciences, Sanofi, Marcy L'Étoile, France., Syrkina O; Patient Safety and Pharmacovigilance, Sanofi R&D, Cambridge, MA, USA., Lyabis O; Global Clinical Development Strategy, Sanofi, Marcy L'Étoile, France., Vasquez GA; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA. gustavo.vasquez@sanofi.com., Rehm C; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA.
Corporate Authors: MET58 Study Group
Source: Infectious diseases and therapy [Infect Dis Ther] 2025 Aug; Vol. 14 (8), pp. 1843-1865. Date of Electronic Publication: 2025 Jul 15.
Publication Type: Journal Article
Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40665158
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martinon-Torres+F%22">Martinon-Torres F</searchLink>; Translational Paediatrics and Infectious Diseases Section, Paediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, 15701, Santiago de Compostela, Spain.; Genetics, Vaccines, and Infections Research Group (GENVIP), Healthcare Research Institute of Santiago de Compostela, University of Santiago de Compostela, 15701, Santiago de Compostela, Spain.; CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, 28222, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Virta+MM%22">Virta MM</searchLink>; Finnish Vaccine Research, Järvenpää Clinic, Mannilantie, Järvenpää, Finland.<br /><searchLink fieldCode="AU" term="%22Koski+S%22">Koski S</searchLink>; Finnish Vaccine Research, Helsinki South Clinic, Vuorikatu, Helsinki, Finland.; Finnish Vaccine Research, Helsinki East Clinic, Itäkeskuksen Kauppakeskus, Agenttitalo, Turunlinnantie, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22de+la+Cueva+IS%22">de la Cueva IS</searchLink>; Unidad de Investigación, Grupo IHP (Instituto Hispalense de Pediatría), Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Szymanski+HT%22">Szymanski HT</searchLink>; Department of Pediatrics, Szpital im. Swietej Jadwigi Slaskiej w Trzebnicy, Prusicka 53-55, 55-100, Trzebnica, Poland.<br /><searchLink fieldCode="AU" term="%22Bosis+S%22">Bosis S</searchLink>; Pneumology and Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Drăgănescu+AC%22">Drăgănescu AC</searchLink>; National Institute for Infectious Diseases 'Prof. Dr. Matei Bals', Bucharest, Romania.; Department of Pediatrics, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.<br /><searchLink fieldCode="AU" term="%22Silfverdal+SA%22">Silfverdal SA</searchLink>; Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.<br /><searchLink fieldCode="AU" term="%22Zambrano+B%22">Zambrano B</searchLink>; Global Clinical Development Strategy, Sanofi, Montevideo, Uruguay.<br /><searchLink fieldCode="AU" term="%22Dhingra+MS%22">Dhingra MS</searchLink>; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA.<br /><searchLink fieldCode="AU" term="%22B'Chir+S%22">B'Chir S</searchLink>; Global Biostatistical Sciences, Sanofi, Marcy L'Étoile, France.<br /><searchLink fieldCode="AU" term="%22Syrkina+O%22">Syrkina O</searchLink>; Patient Safety and Pharmacovigilance, Sanofi R&D, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lyabis+O%22">Lyabis O</searchLink>; Global Clinical Development Strategy, Sanofi, Marcy L'Étoile, France.<br /><searchLink fieldCode="AU" term="%22Vasquez+GA%22">Vasquez GA</searchLink>; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA. gustavo.vasquez@sanofi.com.<br /><searchLink fieldCode="AU" term="%22Rehm+C%22">Rehm C</searchLink>; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22MET58+Study+Group%22">MET58 Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101634499%22">Infectious diseases and therapy</searchLink> [Infect Dis Ther] 2025 Aug; Vol. 14 (8), pp. 1843-1865. <i>Date of Electronic Publication: </i>2025 Jul 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%22">Adis </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101634499 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8229 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221936382%22">21936382 </searchLink><i>NLM ISO Abbreviation: </i>Infect Dis Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40665158
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40121-025-01190-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1843
    Titles:
      – TitleFull: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martinon-Torres F
      – PersonEntity:
          Name:
            NameFull: Virta MM
      – PersonEntity:
          Name:
            NameFull: Koski S
      – PersonEntity:
          Name:
            NameFull: de la Cueva IS
      – PersonEntity:
          Name:
            NameFull: Szymanski HT
      – PersonEntity:
          Name:
            NameFull: Bosis S
      – PersonEntity:
          Name:
            NameFull: Drăgănescu AC
      – PersonEntity:
          Name:
            NameFull: Silfverdal SA
      – PersonEntity:
          Name:
            NameFull: Zambrano B
      – PersonEntity:
          Name:
            NameFull: Dhingra MS
      – PersonEntity:
          Name:
            NameFull: B'Chir S
      – PersonEntity:
          Name:
            NameFull: Syrkina O
      – PersonEntity:
          Name:
            NameFull: Lyabis O
      – PersonEntity:
          Name:
            NameFull: Vasquez GA
      – PersonEntity:
          Name:
            NameFull: Rehm C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2193-8229
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Infectious diseases and therapy
              Type: main
ResultId 1